Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 0.01% vs 0.03% bimatoprost for eyebrow hypotrichosis
TCTR20171130004Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bimatoprost in Eyebrow hypotrichosis, sponsored by Ramathibodi Hospital. Started Jan 2018; status: completed.
02
Drugs
bimatoprost
03
Conditions
Eyebrow hypotrichosis
Beyond the preview
Go deeper on TCTR20171130004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171130004.